Albany,NY (Sept 20, 2013) (CULRAV.ORG) -
Transparency Market Research published new market report “Genomics and Proteomics Reagents, Research Kits and Analytical Instruments Market (Sample Preparation, Electrophoresis, BioChips and Microarrays, Chromatography, Mass Spectrometry, Thermal Cyclers, Next-Gen Sequencing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” in 2012, the global genomics and proteomics reagents, research kits and analytical instruments market was valued at USD 23.8 billion and is expected to grow at a CAGR of 12.1% from 2013 to 2019, to reach an estimated value of USD 52.3 billion in 2019.
Browse full report wih TOC at http://www.transparencymarketresearch.com/proteomics-market.html
The global genomics and proteomics market is expected to experience a growth in revenues at a CAGR of 12.1% during the forecast period, mainly due to exponential growth in preclinical and clinical research in drug discovery and disease identification. Since global incidence rates of cancer, diabetes and genetic diseases are on a rise, the market revenue growth is inevitable. Moreover, other emerging applications such as forensics and agriculture are also contributing to the growth which in turn has increased the number of research projects all over the world particularly in genomics. Proteomics has grown with increasing interest in protein mutations due to changes in genome and has given rise to a unique field of proteogenomics which is carving a commercial position for itself.
Genomics and proteomics reached a major milestone after the completion of Human Genome project in 2001. During the process, the research industry realized the need for affordable methods to sequence genomes of other organisms as well. This led to a revolution in life science analytical research tools and technologies such as thermal cyclers, mass spectrometry, and gel electrophoresis. An impressive genome database of various organisms is available today for researchers through various sources such as gene banks. Advancing technology and miniaturization of memory devices in electronics and semiconductors has also played a very significant role in creating this accomplishment. Several rare and unknown diseases such as autism, Alzheimer’s along with high incidence diseases such as cancer and diabetes are currently being addressed through these technologies by drug discovery, disease 
identification and structural dynamics of proteins.
A large fragmented market indicates high competitive pricing and no loss in quality of products, thus buyers have multiple options to choose from. Unique software for each application and company specified reagents for machines have reduced the negotiating power of buyers as companies do not guarantee good results without usage of company recommended reagents or software solutions. Customer loyalty is very low as researchers are keen to experiment with different products that may yield better results. A high number of acquisitions and mergers in the field of biotechnology indicate the nature of the market. New technological innovations are taking place on a regular basis. Patenting these products and commercializing them is a challenging task for new entrants in the face of giants such as Agilent, Thermo-Scientific, Waters and other players. Thus joint ventures and collaborations with existing players give an excellent platform for new entrants to expand in this field. The threat of new entrants is high and is expected to remain so throughout the forecast period.
Key players leading the genomics and proteomics market are Thermo Fisher Scientific, Agilent Technologies, Life Technologies, Qiagen and Illumina. Intense competition has lowered prices for all types of technologies and is expected to continue further. Miniaturization of technologies such as lab-on-a-chip, biochip and microarray lead the research along with miniaturization of other analytical instruments such as portable mass spectrometers and thermal cyclers.
North America was the largest regional market by revenue in 2012, due to regular break-through innovations in technology that have been introduced in several genomic and proteomic areas. Continued investment in healthcare and medical research is another factor responsible for steady growth in North America. Asia-Pacific and Latin America are expected to show the fastest growth through the forecast period.
The global genomics and proteomics market is segmented into the following categories:
Genomics and Proteomics Market, by Reagent and Research Kits
Sample Preparation Kits
Prepackaged Sample Preparation Kits for PCR
Prepackaged Sample Preparation Kits for Chromatography
Prepackaged Sample Preparation Kits for Mass Spectrometry
Prepackaged Sample Preparation Kits for Electrophoresis
Purification Kits
Electrophoresis Kits
Capillary Electrophoresis
Gel Electrophoresis
BioChips and Microarrays
DNA BioChips and Microarrays
Protein and Peptide BioChips and Microarrays
Genomics and Proteomics Market, by Analytical Instruments
Chromatography
Gas Chromatography
Liquid Chromatography
Mass Spectrometry, by Analyzers
Tandem Mass Spectrometry
Time-Of-Flight Mass Spectrometry
Quadrupole Mass Spectrometry
Fourier Transform Mass Spectrometry
Others (Magnetic Sector, Orbitrap, Ion Trap)
Thermal Cyclers
Digital Thermal Cyclers
Conventional or Traditional Thermal Cyclers
Real-Time Thermal Cyclers
Next Generation Sequencing
Genomics and Proteomics Market, by Geography
North America
Europe
Asia-Pacific
Rest of the World (RoW)
Related Report :
Epigenetics Drugs and Diagnostic Technologies Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 – 2018
http://www.transparencymarketresearch.com/epigenetics-market.html
The research report on the epigenetics drugs and diagnostic technologies market provides detailed analysis of the global market and helps in understanding the driving forces for the growth of these technologies. The report also provides analysis of the drugs market by the mechanism of its action namely, DNMT inhibitors and HDAC inhibitors. The report also discusses the diagnostic technologies market by types which include DNA methylation and ChIP (Chromatin Immunoprecipitation) technology. Market size estimates and forecasts for the period 2010 to 2018 has been given for each segment and sub-segment, in terms of USD million, using 2010 as the base year.
The market has also been segmented geographically into four regions namely North America, Europe, Asia-Pacific, and Rest of the World (RoW). Market size and forecast has been provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the epigenetics market and future opportunities are provided in the report.
About Us:
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Browse full report wih TOC at http://www.transparencymarketresearch.com/proteomics-market.html
Related Posts
Global Pain Management Therapeutics Market Will Decline USD 29.47 Billion in 2018 : Transparency Market Research
Global Pain Management Therapeutics Market Will Decline to USD 29.47 Billion by 2018: Transparency Market Research
Global Molecular Cytogenetics Market Will Reach USD 1.97 Billion in 2019: Transparency Market Research
Global Epigenetics Drugs and Diagnostic Technologies Market Will Reach USD 5.7 Billion Globally in 2018: Transparency Market Research
Global Pain Management Devices Market Will Reach USD 5.0 Billion in 2018: Transparency Market Research
This Press Release (Global Genomics and Proteomics Reagents, Research Kits and Analytical Instruments Market Will Reach USD 52.3 Billion in 2019: Transparency Market Research) Distributed By CULRAV.ORG http://www.culrav.org